Arcadia Data is a technology company.
Arcadia Data has raised $27.0M across 2 funding rounds.
Arcadia Data has raised $27.0M in total across 2 funding rounds.
# Arcadia Data: Healthcare Analytics Platform
There are two distinct companies named Arcadia operating in different sectors. The primary subject here is Arcadia (arcadia.io), a healthcare data analytics platform founded in 2002 and headquartered in Boston[2]. Arcadia builds an industry-leading platform that integrates and harmonizes data from across the healthcare ecosystem, transforming it into actionable insights for providers, payers, and government organizations[2]. The company solves a critical problem: healthcare organizations struggle to extract actionable intelligence from fragmented, complex data sources. Arcadia's solution combines scalable technology, AI-driven intelligence, and performance benchmarks to support clinical and financial performance improvements[2].
The company has demonstrated sustained growth, earning recognition on the Inc. 5000 list of fastest-growing private companies for the ninth consecutive time as of 2025[2]. Its customer base spans national and regional health systems, major payers, and governmental organizations across North America[2].
Arcadia was founded in 2002 with a vision to transform healthcare through data-driven decision-making[2]. The company emerged from the recognition that healthcare—an industry dealing with the most precious resource (human life)—should be the most data-driven sector in the world[3]. The founding team comprised experienced professionals from the value-based care, technology, and healthcare analytics spaces, bringing deep expertise in how data and tools can help organizations answer their most pressing questions[3].
The company's evolution reflects the broader shift toward data-driven healthcare. Over two decades, Arcadia has built an active electronic health record and claims-based patient population growing at 35%, with comprehensive visibility across multiple payers, multiple sites of care, and the entire clinical patient journey[5].
Arcadia operates at the intersection of several powerful trends reshaping healthcare. The industry is experiencing a fundamental shift toward value-based care models, where financial incentives align with patient outcomes rather than volume of services. This shift creates urgent demand for the kind of integrated analytics Arcadia provides[2].
The company also benefits from the broader healthcare data interoperability movement. As regulatory pressure increases for data sharing and patient access, platforms that can safely harmonize data across fragmented systems become increasingly valuable[3]. Arcadia's role in this ecosystem extends beyond its direct customers—through partnerships with data connectivity platforms, it enables a broader network of life sciences and research organizations to access high-quality real-world data[5].
Additionally, Arcadia is positioned within the growing healthtech sector, where AI and advanced analytics are becoming table stakes for competitive advantage. The company's consistent recognition as one of America's fastest-growing companies reflects investor and market confidence in this thesis[2].
Arcadia's trajectory suggests continued expansion in an increasingly data-hungry healthcare market. The company's focus on embedding actionable insight across the care continuum positions it well as healthcare organizations face mounting pressure to improve outcomes while controlling costs[3]. The partnership ecosystem—particularly with data connectivity platforms—indicates a strategy to become a central node in healthcare's data infrastructure rather than a standalone tool.
Looking ahead, Arcadia's influence will likely grow as value-based care models proliferate and regulatory frameworks increasingly mandate interoperability. The company's ability to help organizations "answer their biggest questions" through integrated data will become more strategically critical, not less. For investors and stakeholders, Arcadia represents a bet on the inevitable datafication of healthcare—a transformation that has only accelerated since the company's 2002 founding.
Arcadia Data has raised $27.0M in total across 2 funding rounds.
Arcadia Data's investors include Brand Foundry Ventures, Caffeinated Capital, Consumer Ventures, Jackson Square Ventures, Keiretsu Capital, Listen, Mayfield, Partech Ventures, Pelion Venture Partners, Renegade Partners, Social Capital, Zetta Venture Partners.
Arcadia Data has raised $27.0M across 2 funding rounds. Most recently, it raised $15.0M Series B in October 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2018 | $15.0M Series B | Brand Foundry Ventures, Caffeinated Capital, Consumer Ventures, Jackson Square Ventures, Keiretsu Capital, Listen, Mayfield, Partech Ventures, Pelion Venture Partners, Renegade Partners, Social Capital, Zetta Venture Partners, Chris Cooper, Seth Goldstein | |
| Jun 1, 2015 | $12.0M Series A | Brand Foundry Ventures, Caffeinated Capital, Consumer Ventures, Keiretsu Capital, Listen, Mayfield, Renegade Partners, Social Capital, Seth Goldstein |